Literature DB >> 25251907

Shear stress-associated acquired von Willebrand syndrome in patients with mitral regurgitation.

J L Blackshear1, E M Wysokinska, R E Safford, C S Thomas, B P Shapiro, S Ung, M E Stark, P Parikh, G S Johns, D Chen.   

Abstract

BACKGROUND: Mitral valve regurgitation is associated with an acquired hemostatic defect.
OBJECTIVE: We sought to assess the prevalence and severity of acquired von Willebrand syndrome in patients with native valve mitral regurgitation (MR). PATIENTS/
METHODS: Fifty-three patients were prospectively observed with bleeding questionnaires and laboratory tests when undergoing an echocardiographic assessment of MR. In patients referred for mitral valve surgery, testing was repeated postoperatively.
RESULTS: Echocardiography identified 13 patients with mild MR, 14 with moderate MR, and 26 with severe MR. Among patients with mild, moderate or severe MR, loss of the highest molecular weight von Willebrand factor (VWF) multimers occurred in 8%, 64%, and 85%, respectively, median platelet function analyzer collagen ADP closure times (PFA-CADPs) were 84 s (interquartile range [IQR] 73-96 s), 156 s (IQR 104-181 s), and 190 s (IQR 157-279 s), respectively, and the ratios of VWF latex activity to antigen were 0.92 (IQR 0.83-0.97), 0.85 (IQR 0.76-0.89), and 0.79 (IQR 0.75-0.82), respectively (all P < 0.001). Nine patients reported clinically significant bleeding, and seven had intestinal angiodysplasia and transfusion-dependent gastrointestinal bleeding (Heyde syndrome), with the median number of transfusions required being 20 (IQR 10-33; range 4-50). In patients who underwent mitral valve repair (n = 13) or replacement (n = 7), all measures of VWF function reported above improved significantly.
CONCLUSION: The high-shear environment of moderate to severe MR is sufficient to produce prevalent perturbations in VWF activity. Acquired von Willebrand syndrome may occur in this setting, and appears to be reversible with mitral valve surgery.
© 2014 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  gastrointestinal hemorrhage; hemorrhage; mitral valve insufficiency; von Willebrand diseases; von Willebrand factor

Mesh:

Substances:

Year:  2014        PMID: 25251907     DOI: 10.1111/jth.12734

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  11 in total

1.  Von Willebrand factor multimers during transcatheter aortic valve replacement-an additional clue for detecting post-procedural aortic regurgitation?

Authors:  Andras Peter Durko; Arie Pieter Kappetein
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  High Molecular Weight von Willebrand Factor Multimer Loss and Bleeding in Patients with Short-Term Mechanical Circulatory Support Devices: A Case Series.

Authors:  Michael Goldfarb; Lawrence S Czer; Lee D Lam; Jaime Moriguchi; Francisco A Arabia; Oksana Volod
Journal:  J Extra Corpor Technol       Date:  2018-06

3.  Reduction of Gastrointestinal Bleeding in Patients With Heyde Syndrome Undergoing Transcatheter Aortic Valve Implantation.

Authors:  Lia C M J Goltstein; Maxim J P Rooijakkers; Natasha C C Görtjes; Reinier P Akkermans; Erwin S Zegers; Ron Pisters; Marleen H van Wely; Kees van der Wulp; Joost P H Drenth; Erwin J M van Geenen; Niels van Royen
Journal:  Circ Cardiovasc Interv       Date:  2022-07-05       Impact factor: 7.514

Review 4.  Gastrointestinal Bleeding in Native and Prosthetic Valve Disease.

Authors:  Joseph L Blackshear
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-03

Review 5.  Transport physics and biorheology in the setting of hemostasis and thrombosis.

Authors:  L F Brass; S L Diamond
Journal:  J Thromb Haemost       Date:  2016-03-30       Impact factor: 5.824

6.  Impact of heart failure on stroke mortality and recurrence.

Authors:  Tiberiu A Pana; Adrian D Wood; Jesus A Perdomo-Lampignano; Somsak Tiamkao; Allan B Clark; Kannikar Kongbunkiat; Joao H Bettencourt-Silva; Kittisak Sawanyawisuth; Narongrit Kasemsap; Mamas A Mamas; Phyo K Myint
Journal:  Heart Asia       Date:  2019-04-20

7.  Hemostatic abnormalities in adult patients with Marfan syndrome.

Authors:  Katharina T I Kornhuber; Heide Seidel; Claudia Pujol; Christian Meierhofer; Franz Röschenthaler; Axel Pressler; Alexander Stöckl; Nicole Nagdyman; Rhoia C Neidenbach; Philipp von Hundelshausen; Martin Halle; Stefan Holdenrieder; Peter Ewert; Harald Kaemmerer; Michael Hauser
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

8.  Dynamics of Blood Flows in Aortic Stenosis: Mild, Moderate, and Severe.

Authors:  Choon-Sik Jhun; Raymond Newswanger; Joshua P Cysyk; Sailahari Ponnaluri; Bryan Good; Keefe B Manning; Gerson Rosenberg
Journal:  ASAIO J       Date:  2021-06-01       Impact factor: 3.826

9.  A Risk Assessment of Factors for the Presence of Angiodysplasias During Endoscopy and Factors Contributing to Symptomatic Bleeding and Rebleeds.

Authors:  K V Grooteman; G Holleran; M Matheeuwsen; E J M van Geenen; D McNamara; J P H Drenth
Journal:  Dig Dis Sci       Date:  2019-06-12       Impact factor: 3.199

10.  Von Willebrand factor multimer quantitation for assessment of cardiac lesion severity and bleeding risk.

Authors:  Christopher O Austin; Dong Chen; Colleen S Thomas; Robert E Safford; Brian P Shapiro; Justin A Bryan; Jordan C Ray; Joseph L Blackshear
Journal:  Res Pract Thromb Haemost       Date:  2017-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.